{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:13:40Z","timestamp":1791915220934,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81770620"],"award-info":[{"award-number":["81770620"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300319"],"award-info":[{"award-number":["81300319"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12967-019-1900-9","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T10:03:48Z","timestamp":1557482628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Apolipoprotein A5 alleviates LPS\/d-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-\u03baB pathway"],"prefix":"10.1186","volume":"17","author":[{"given":"Ya-Chao","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En-Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"issue":"4","key":"1900_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.4037\/aacnacc2016324","volume":"27","author":"A Grek","year":"2016","unstructured":"Grek A, Arasi L. Acute liver failure. Aacn Adv Crit Care. 2016;27(4):420\u20139.","journal-title":"Aacn Adv Crit Care"},{"key":"1900_CR2","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. Electronic address eee, Clinical practice guidelines p, Wendon J, Panel m, Cordoba J, Dhawan A, Larsen FS, Manns M, Samuel D, Simpson KJ et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017;66(5):1047\u20131081.","DOI":"10.1016\/j.jhep.2016.12.003"},{"issue":"1","key":"1900_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bpg.2012.01.012","volume":"26","author":"J O'Grady","year":"2012","unstructured":"O'Grady J. Liver transplantation for acute liver failure. Best Pract Res Clin Gastroenterol. 2012;26(1):27\u201333.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"9","key":"1900_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/lt.23492","volume":"18","author":"CM Lo","year":"2012","unstructured":"Lo CM. Living donor liver transplantation for acute liver failure: no other choice. Liver Transpl. 2012;18(9):1005\u20136.","journal-title":"Liver Transpl"},{"issue":"2","key":"1900_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1373\/clinchem.2004.044826","volume":"51","author":"V Charlton-Menys","year":"2005","unstructured":"Charlton-Menys V, Durrington PN. Apolipoprotein A5 and hypertriglyceridemia. Clin Chem. 2005;51(2):295\u20137.","journal-title":"Clin Chem"},{"issue":"5540","key":"1900_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.1064852","volume":"294","author":"LA Pennacchio","year":"2001","unstructured":"Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001;294(5540):169\u201373.","journal-title":"Science"},{"issue":"7","key":"1900_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11883-017-0665-y","volume":"19","author":"M Guardiola","year":"2017","unstructured":"Guardiola M, Ribalta J. Update on APOA5 genetics: toward a better understanding of its physiological impact. Curr Atheroscler Rep. 2017;19(7):30.","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"1900_CR8","first-page":"76","volume":"103","author":"RC Maranhao","year":"2014","unstructured":"Maranhao RC, Carvalho PO, Strunz CC, Pileggi F. Lipoprotein (a): structure, pathophysiology and clinical implications. Arq Bras Cardiol. 2014;103(1):76\u201384.","journal-title":"Arq Bras Cardiol"},{"issue":"5","key":"1900_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.bbalip.2010.02.004","volume":"1801","author":"X Shu","year":"2010","unstructured":"Shu X, Nelbach L, Ryan RO, Forte TM. Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation. Biochim Biophys Acta. 2010;1801(5):605\u20138.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1900_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1194\/jlr.M010793","volume":"52","author":"AM Blade","year":"2011","unstructured":"Blade AM, Fabritius MA, Hou L, Weinberg RB, Shelness GS. Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion. J Lipid Res. 2011;52(2):237\u201344.","journal-title":"J Lipid Res"},{"issue":"5","key":"1900_CR11","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.1016\/j.orcp.2012.08.192","volume":"7","author":"Y Yoshino","year":"2013","unstructured":"Yoshino Y, Okada T, Abe Y, Odaka M, Kuromori Y, Yonezawa R, Iwata F, Mugishima H. Apolipoprotein A-V level may contribute to the development of obesity-associated dyslipidemia. Obes Res Clin Pract. 2013;7(5):e415\u2013419.","journal-title":"Obes Res Clin Pract"},{"issue":"2","key":"1900_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.atherosclerosis.2009.12.004","volume":"210","author":"XS Huang","year":"2010","unstructured":"Huang XS, Zhao SP, Hu M, Bai L, Zhang Q, Zhao W. Decreased apolipoprotein A5 is implicated in insulin resistance-related hypertriglyceridemia in obesity. Atherosclerosis. 2010;210(2):563\u20138.","journal-title":"Atherosclerosis"},{"issue":"12","key":"1900_CR13","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1007\/s00268-012-1770-2","volume":"36","author":"LT Hoekstra","year":"2012","unstructured":"Hoekstra LT, van Lienden KP, Schaap FG, Chamuleau RA, Bennink RJ, van Gulik TM. Can plasma bile salt, triglycerides, and apoA-V levels predict liver regeneration? World J Surg. 2012;36(12):2901\u20138.","journal-title":"World J Surg"},{"key":"1900_CR14","doi-asserted-by":"publisher","first-page":"45576","DOI":"10.1038\/srep45576","volume":"7","author":"EQ Chen","year":"2017","unstructured":"Chen EQ, Wang ML, Zhang DM, Shi Y, Wu DB, Yan LB, Du LY, Zhou LY, Tang H. Plasma apolipoprotein A-V predicts long-term survival in chronic hepatitis B patients with acute-on-chronic liver failure. Sci Rep. 2017;7:45576.","journal-title":"Sci Rep"},{"key":"1900_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.freeradbiomed.2015.08.023","volume":"89","author":"X Xia","year":"2015","unstructured":"Xia X, Fu J, Song X, Shi Q, Su C, Song E, Song Y. Neohesperidin dihydrochalcone down-regulates MyD88-dependent and-independent signaling by inhibiting endotoxin-induced trafficking of TLR4 to lipid rafts. Free Radic Biol Med. 2015;89:522\u201332.","journal-title":"Free Radic Biol Med"},{"key":"1900_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.intimp.2017.03.003","volume":"46","author":"X Gong","year":"2017","unstructured":"Gong X, Yang Y, Huang L, Zhang Q, Wan RZ, Zhang P, Zhang B. Antioxidation, anti-inflammation and anti-apoptosis by paeonol in LPS\/d-GalN-induced acute liver failure in mice. Int Immunopharmacol. 2017;46:124\u201332.","journal-title":"Int Immunopharmacol"},{"key":"1900_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0091-679X(08)61921-4","volume":"46","author":"JF Kerr","year":"1995","unstructured":"Kerr JF, Gobe GC, Winterford CM, Harmon BV. Anatomical methods in cell death. Methods Cell Biol. 1995;46:1\u201327.","journal-title":"Methods Cell Biol"},{"issue":"1\u20132","key":"1900_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000337585","volume":"29","author":"Z Ben Ari","year":"2012","unstructured":"Ben Ari Z, Avlas O, Pappo O, Zilbermints V, Cheporko Y, Bachmetov L, Zemel R, Shainberg A, Sharon E, Grief F, et al. Reduced hepatic injury in toll-like receptor 4-deficient mice following d-galactosamine\/lipopolysaccharide-induced fulminant hepatic failure. Cell Physiol Biochem. 2012;29(1\u20132):41\u201350.","journal-title":"Cell Physiol Biochem"},{"key":"1900_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jcrc.2017.01.003","volume":"39","author":"FS Cardoso","year":"2017","unstructured":"Cardoso FS, Marcelino P, Bagulho L, Karvellas CJ. Acute liver failure: an up-to-date approach. J Crit Care. 2017;39:25\u201330.","journal-title":"J Crit Care"},{"issue":"48","key":"1900_CR20","doi-asserted-by":"publisher","first-page":"44512","DOI":"10.1074\/jbc.M106888200","volume":"276","author":"HN van der Vliet","year":"2001","unstructured":"van der Vliet HN, Sammels MG, Leegwater AC, Levels JH, Reitsma PH, Boers W, Chamuleau RA. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem. 2001;276(48):44512\u201320.","journal-title":"J Biol Chem"},{"issue":"4","key":"1900_CR21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jhep.2004.06.026","volume":"41","author":"T Takayashiki","year":"2004","unstructured":"Takayashiki T, Yoshidome H, Kimura F, Ohtsuka M, Shimizu Y, Kato A, Ito H, Shimizu H, Ambiru S, Togawa A, et al. Increased expression of toll-like receptor 4 enhances endotoxin-induced hepatic failure in partially hepatectomized mice. J Hepatol. 2004;41(4):621\u20138.","journal-title":"J Hepatol"},{"key":"1900_CR22","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.biopha.2018.07.034","volume":"106","author":"T Fu","year":"2018","unstructured":"Fu T, Li H, Zhao Y, Cai E, Zhu H, Li P, Liu J. Hepatoprotective effect of alpha-mangostin against lipopolysaccharide\/d-galactosamine-induced acute liver failure in mice. Biomed Pharmacother. 2018;106:896\u2013901.","journal-title":"Biomed Pharmacother"},{"issue":"4\u20136","key":"1900_CR23","first-page":"256","volume":"108","author":"A Salles","year":"2014","unstructured":"Salles A, Romano A, Freudenthal R. Synaptic NF-kappa B pathway in neuronal plasticity and memory. J Physiol. 2014;108(4\u20136):256\u201362.","journal-title":"J Physiol"},{"issue":"11","key":"1900_CR24","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.4049\/jimmunol.164.11.5564","volume":"164","author":"AE Medvedev","year":"2000","unstructured":"Medvedev AE, Kopydlowski KM, Vogel SN. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol. 2000;164(11):5564\u201374.","journal-title":"J Immunol"},{"issue":"2","key":"1900_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.intimp.2015.02.015","volume":"25","author":"EB Byun","year":"2015","unstructured":"Byun EB, Sung NY, Park JN, Yang MS, Park SH, Byun EH. Gamma-irradiated resveratrol negatively regulates LPS-induced MAPK and NF-kappaB signaling through TLR4 in macrophages. Int Immunopharmacol. 2015;25(2):249\u201359.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"1900_CR26","doi-asserted-by":"publisher","first-page":"e87810","DOI":"10.1371\/journal.pone.0087810","volume":"9","author":"J Li","year":"2014","unstructured":"Li J, Zhong W, Wang W, Hu S, Yuan J, Zhang B, Hu T, Song G. Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-kappaB activation. PLoS ONE. 2014;9(2):e87810.","journal-title":"PLoS ONE"},{"key":"1900_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3389\/fphar.2017.00547","volume":"8","author":"P Cheng","year":"2017","unstructured":"Cheng P, Wang T, Li W, Muhammad I, Wang H, Sun X, Yang Y, Li J, Xiao T, Zhang X. Baicalin alleviates lipopolysaccharide-induced liver inflammation in chicken by suppressing TLR4-mediated NF-kappaB pathway. Front Pharmacol. 2017;8:547.","journal-title":"Front Pharmacol"},{"key":"1900_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jep.2015.10.029","volume":"176","author":"H Liu","year":"2015","unstructured":"Liu H, Zhang W, Dong S, Song L, Zhao S, Wu C, Wang X, Liu F, Xie J, Wang J, et al. Protective effects of sea buckthorn polysaccharide extracts against LPS\/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-kappaB signaling. J Ethnopharmacol. 2015;176:69\u201378.","journal-title":"J Ethnopharmacol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1900-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-1900-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1900-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:13:09Z","timestamp":1588965189000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-1900-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1900"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-1900-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}